In the last trading session, 0.12 million Mural Oncology plc (NASDAQ:MURA) shares changed hands as the company’s beta touched 3.95. With the company’s per share price at $3.24 changed hands at -$0.05 or -1.52% during last session, the market valuation stood at $57.84M. MURA’s last price was a discount, traded about -92.9% off its 52-week high of $6.25. The share price had its 52-week low at $2.87, which suggests the last value was 11.42% up since then. When we look at Mural Oncology plc’s average trading volume, we note the 10-day average is 0.16 million shares, with the 3-month average coming to 154.52K.
Analysts gave the Mural Oncology plc (MURA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MURA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Mural Oncology plc’s EPS for the current quarter is expected to be -1.98.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mural Oncology plc (NASDAQ:MURA) trade information
However, in the 30-day time frame, Mural Oncology plc (NASDAQ:MURA) is 1.19% up. Looking at the short shares, we see there were 0.41 million shares sold at short interest cover period of 3.85 days.
Mural Oncology plc (MURA) estimates and forecasts
Data shows that the Mural Oncology plc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 10.42% over the past 6 months, a 39.34% in annual growth rate that is considerably higher than the industry average of 16.40%.
The 2024 estimates are for Mural Oncology plc earnings to increase by 39.04%.
MURA Dividends
Mural Oncology plc is expected to release its next quarterly earnings report in January.
